Queen's University spinout Fusion Antibodies is targeting $7.4m in proceeds in an IPO that will provide an exit to Qubis and Invest NI.
Fusion Antibodies, a UK-based genomics modelling platform spun out of Queen’s University Belfast, will raise £5.5m ($7.4m) in its initial public offering on Aim, the Irish News reported today.
The flotation will value Fusion Antibodies at £18.1m and provide an exit to Queen’s University’s commercialisation arm Qubis as well as state-owned economic development agency Invest NI, which most recently put $103,000 into the business in 2013.
Founded in 2001, Fusion Antibodies provides model antibodies to drug discovery businesses seeking…
